Skip Navigation



NDT Advance Access published online on October 28, 2009
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfp538
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ponticelli, C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ponticelli, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.For Permissions, please e-mail: journals.permissions@oxfordjournals.org


Recurrence of focal segmental glomerular sclerosis (FSGS) after renal transplantation

Claudio Ponticelli

Division of Nephrology, Istituto Scientifico Humanitas, via Manzoni 56, 20089 Rozzano, Milano, Italy

Correspondence and offprint requests to: Correspondence and offprint requests to: Claudio Ponticelli; E-mail: claudio.ponticelli@fastwebnet.it

The first 150 words of the full text of this article appear below.

Focal segmental glomerular sclerosis (FSGS) is a pathological term to indicate glomerular lesions associated with distinctive clinical features. In most cases, FSGS is primary in nature and is called idiopathic. Idiopathic FSGS is often associated with a nephrotic syndrome (NS) and may affect both children and adults. While the prognosis of FSGS is relatively good for patients with subnephrotic proteinuria, most patients with persisting proteinuria progress to end stage renal disease (ESRD) in spite of glucocorticoid or immunosuppressive treatment. For most of these patients, renal transplantation should be considered as the treatment of choice. However, in FSGS, the success of renal transplantation may be impaired by the frequent risk of recurrence of the disease on the allograft and by the poor graft survival rate in patients with recurrence.

This paper will focus on the risk factors for recurrence, the possible pathogenesis of recurrence and the clinical results of renal transplantation . . . [Full Text of this Article]



   Risk factors for recurrence
 


   Clinical presentation
 


   Pathogenesis
 


   Clinical course and prognosis
 


   Treatment
 


   Conclusions and practical recommendations
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?